Literature DB >> 26829918

Epilepsy.

Kaarkuzhali B Krishnamurthy.   

Abstract

This issue provides a clinical overview of epilepsy, focusing on diagnosis, prevention, treatment, and further considerations. The content of In the Clinic is drawn from the clinical information and education resources of the American College of Physicians (ACP), including MKSAP (Medical Knowledge and Self-Assessment Program). Annals of Internal Medicine editors develop In the Clinic in collaboration with the ACP's Medical Education and Publishing divisions and with the assistance of additional science writers and physician writers.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26829918     DOI: 10.7326/AITC201602020

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  4 in total

1.  Inhibition of miR-181a-5p reduces astrocyte and microglia activation and oxidative stress by activating SIRT1 in immature rats with epilepsy.

Authors:  Huimin Kong; Huaili Wang; Zhihong Zhuo; Zhenbiao Li; Peichao Tian; Jing Wu; Jian Liu; Zheng Chen; Jiyao Zhang; Qiang Luo
Journal:  Lab Invest       Date:  2020-05-27       Impact factor: 5.662

2.  Comprehensive analysis of presurgical factors predicting psychiatric disorders in patients with refractory temporal lobe epilepsy and mesial temporal sclerosis underwent cortico-amygdalohippocampectomy.

Authors:  Wei Yang; Chongyi Chen; Bo Wu; Qiaoyu Yang; Dongdong Tong
Journal:  J Clin Lab Anal       Date:  2018-12-05       Impact factor: 2.352

3.  Mitochondrial DNA analyses found five novel mutations in idiopathic epilepsy patients.

Authors:  Cuiping You; Rui Tao; Quanping Su; Yucheng Lu; Long Wang; Shu Liu; Lifen Wang; Lijuan Wang; Fuzhong Xue; Fengyuan Che
Journal:  Mitochondrial DNA B Resour       Date:  2019-07-12       Impact factor: 0.658

4.  Validation of the Chinese Version of the Stigma Scale of Epilepsy.

Authors:  Yuanxia Wu; Kailing Huang; Shirui Wen; Bo Xiao; Li Feng
Journal:  Front Neurol       Date:  2022-02-07       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.